Katharina Elisabeth Grafinger

18PUBLICATIONS
38CO-AUTHORS
Biologically active moleculesFlight dynamicsCheminformatics and quantitative structure-activity relationshipsInstrumental methods (excl. immunological and bioassay methods)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 12, 2026
Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances.

|Jun 02, 2026
Investigation of the In Vitro and In Vivo Metabolism and μ-Opioid Receptor Affinity of the Nitazene N-Pyrrolidino Fluetonitazene.

|Dec 22, 2025
Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well-documented intoxication cases and basic pharmacological data.

Michaela J Sommer, Katharina Elisabeth Grafinger, Maren Hermanns-Clausen

|Aug 08, 2024
Interpreting mono- and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure.

Liesl K Janssens, Michaela J Sommer, Katharina Elisabeth Grafinger

|Mar 13, 2024
Analysing and quantifying chronic stress-associated endogenous steroids in hair samples.

Katharina Elisabeth Grafinger, Wassilis Kassis, Céline A Favre

|Mar 09, 2024
Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine.

Marianne Skov-Skov Bergh, Inger Lise Bogen, Katharina Elisabeth Grafinger

Pageof 3

Frequent Collaborators

7 joint publications

Volker Auwärter

6 joint publications

Christophe Stove

5 joint publications

Wolfgang Weinmann

4 joint publications

Samuel D Banister